Market›Health Care›Biotechnology›Biotechnology
Theralink Technologi

THER

$0.00May 14, 2021 – May 13, 2026
Health CareBiotechnology$0M
MVM
+$0.0M
PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Chart Start
$0.96
2021
Since 2021
-100.0%
vs SPY +78.2%
All-time High
$7.00 · Oct 2021
-100.0% from peak
MVM Rank
#245 of 558
Biotechnology
Reaction Win Rate
33%
9 of 27 events

Theralink Technologi has returned -100.0% from $0.96 since 2021, trailing SPY's +78.2% over the same period. The stock hit an all-time high of $7.00 in Oct 2021 and is currently 100.0% below that level. Of 27 tracked news events, 33% produced a positive market-adjusted return.

How to use this page
1Company Research Snapshot

Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.

2Company Q&A

Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.

3News & Events

Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.

Company Q&AShow ▼
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-05-29-84.4%executiveThe Business JournalsIMAC Holdings names Faith Zaslavsky as CEO - The Business Journals
2022-04-06-32.8%executiveSEC EDGARTHER 8-K: 5.02 (SEC Filing)
2023-02-01-28.2%M&ASEC EDGARTHER 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2021-11-29-25.4%M&ASEC EDGARTHER 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2023-06-29+23.4%executiveSEC EDGARTHER 8-K: 5.02, 7.01 (SEC Filing)
2023-06-27-21.1%executiveSeeking AlphaTheralink names Faith Zaslavsky as CEO
2021-11-05-20.8%M&ASEC EDGARTHER 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2022-12-09+18.7%executiveSEC EDGARTHER 8-K: 5.02, 7.01 (SEC Filing)
2023-11-28-16.7%newsSEC EDGARTHER 8-K: 8.01 (SEC Filing)
2022-02-03-16.1%M&ASEC EDGARTHER 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2021-08-06+15.9%M&ASEC EDGARTHER 8-K: 1.01, 3.02, 5.03 (SEC Filing)
2024-05-07-14.4%M&AGlobeNewswireIMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business - GlobeNewswire
2022-07-25+13.9%M&ASeeking AlphaTheralink acquires two new milestone patents for breast cancer treatment
2022-08-10-11.2%newsStock TitanLatest BACK News - Ignite Proteomics Announces Collaboration w... - Stock Titan
2021-05-19+10.3%M&ASEC EDGARTHER 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2023-05-23-9.3%M&ASeeking AlphaIMAC Holdings up 25% on acquisition of Theralink
2022-12-01-9.0%M&ASEC EDGARTHER 8-K: 1.01, 2.03, 3.02, 8.01 (SEC Filing)
2023-05-26-7.2%M&ASEC EDGARTHER 8-K: 1.01, 8.01 (SEC Filing)
2022-12-06-7.0%executiveSeeking AlphaTheralink Technologies appoints Faith Zaslavsky, as President & COO
2022-09-16+6.1%M&ASEC EDGARTHER 8-K: 1.01, 2.03 (SEC Filing)
2022-02-25-5.1%newsSeeking AlphaTheralink Technologies announces change of ticker symbol and CUSIP
2026-04-08-3.1%M&AMinichartIgnite Proteomics LLC Reports 2025 Financial Results and Acquisition by Aditxt, Inc - Minichart
2022-01-05+2.0%executiveSEC EDGARTHER 8-K: 5.02 (SEC Filing)
2025-04-25-0.8%newsStock TitanSYBE Stock Price, News & Analysis - Stock Titan
2025-04-25-0.8%newsStock TitanBIOAF Stock Price, News & Analysis - Stock Titan
2023-05-11+0.3%executiveSEC EDGARTHER 8-K: 5.02 (SEC Filing)
2022-11-01+0.2%newsGuruFocusAndrew Albert Kucharchuk Net Worth (2026) - GuruFocus
tickerdossier.comtickerdossier.substack.com